Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current online issue of the Proceedings of the National Academy of Sciences … Read the full story from the UCSD Newsroom
M. Geoff Rosenfeld, MD, is an investigator in the study. Dr. Rosenfeld is professor of medicine in the Division of Endocrinology and Metabolism and a Howard Hughes Medical Institute investigator. | Read the article in the Proceedings of the National Academy of Sciences.